Llwytho...
Zoledronic Acid-Containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor
Bisphosphonates are generally used to treat bone diseases, such as bone metastasis from cancer. There is evidence that, through the modification of the pharmacokinetics and biodistribution of bisphosphonates by formulating them into nanoparticles, they may be able to treat extraskeletal tumors. Howe...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ACS Appl Mater Interfaces |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582365/ https://ncbi.nlm.nih.gov/pubmed/30689348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsami.8b16588 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|